Effect of fish oils containing different amounts of EPA, DHA, and antioxidants on plasma and brain fatty acids and brain nitric oxide synthase activity in rats

Upsala Journal of Medical Sciences

Volumn 114, Issue 4, 2009, Pages 206-213

  Engstrm, Karin ^a   Saldeen, Ann Sofie ^b   Yang, Baichun ^c   Mehta, Jawahar L ^c   Saldeen, Tom ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Antioxidants; Brain; DHA; EPA; Fish oil; Lipid peroxidation; Nitric oxide synthase

Indexed keywords

ANTIOXIDANT; DOCOSAHEXAENOIC ACID; EDIBLE OIL; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; LIPOPROTEIN; NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, RAT; PHOSPHOLIPID;

ANIMAL; ARTICLE; BLOOD; BRAIN; CHEMISTRY; DRUG EFFECT; DRUG STABILITY; LIPID PEROXIDATION; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; BRAIN; DIETARY FATS, UNSATURATED; DOCOSAHEXAENOIC ACIDS; DRUG STABILITY; EICOSAPENTAENOIC ACID; FATTY ACIDS; FISH OILS; LIPID PEROXIDATION; LIPOPROTEINS; MALE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPIDS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 72449148190     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009730903268958     Document Type: Article

References (44)

1. Burr ML, Fehily AM, Gilbert JF. Effects of changes in fat, fish and fiber intakes on health and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;334:757-761
2. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447-455
3. Mazza M, Pomponi M, Janiri L, Bria P, Mazza S. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:12-26.
4. Chapman PF, Atkins CM, Allen MT, Haley JE, Steinmetz JE. Inhibition of nitric oxide synthesis impairs two different forms of learning. Neuroreport. 1992;3:567-570
5. Bohme GA, Bon C, Lemaire M, Reibaud M, Piot O, Stutzmann JM, et al. Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc Natl Acad Sci USA. 1993;90:9191-9194
6. Ingram DK, Spangler EL, Iijima S, Kuo H, Bresnahan EL, Greig NH, et al. New pharmacological strategies for cognitive enhancement using a rat model of age-related memory impairment. Ann N Y Acad Sci. 1994;717:16-32.
7. Holscher C, McGlinchey R, Anwyl R, Rowman MJ. 7-Nitro indazole, a selective neuronal nitric oxide synthase inhibitor in vivo, impairs spatial learning in the rat. Learn Mem. 1996;2:267-278
8. Prast H, Philippu A. Nitric oxide as a modulator of neural function. Prog Neurobiol. 2001;64:51-68.
9. Kanit L, Koylu EO, Yararbas G, Furedy J, Pogun S. The effect of nitric oxide synthase inhibition on cognitive ability and strategies employed for place learning in the water maze: sex differences. Brain Res. Bull. 2003;62:151-159
10. Frankel EN. Lipid oxidation. Dundee, Scotland: The Oily Press Ltd; 1998.
11. Saldeen T, Engstrom K, Jokela R, Wallin R. Importance of in vitro stability for in vivo effects of fish oil. In: Cambridge, UK: Natural antioxidants and anticarcinogens in nutrition, health and disease. Special Publication 240.; 1999. p. 326-330
12. Kaasgaard SG, Hølmer G, Høy CE, Behrens WA, Beare- Rogers JL. Effects of dietary linseed oil and marine oil on lipid peroxidation in monkey liver in vivo and in vitro. Lipids. 1992;27:740-745
13. Johansen O. Studies on coronary angioplasty, restenosis and very long chain n-3 fatty acids [Doctoral thesis]. Oslo, Norway: Department of Cardiology, Ulleval Hospital, University of Oslo; 1999.
14. Saldeen T, Mehta JL. Dietary modulations in the prevention of coronary artery disease: A special emphasis on vitamins and fish oil. Curr Opin Cardiol. 2002;17:559-567
15. Wong SHY, Knight JA, Hopfer SM, Zaharia O, Leach CNJr, Sunderman FWJr. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehydethiobarbituric acid adduct. Clin Chem. 1987;33:214-220
16. Engstrøm K, Wallin R, Saldeen T. Effects of Scandinavian caviar paste enriched with a stable fish oil on plasma phospholipid fatty acids and lipid peroxidation. Eur J Clin Nutr. 2003;57:1052-1059
17. Öhrvall M, Tengblad S, Vessby B. Lower tocopherol serum levels in subjects with abdominal adiposity. J Intern Med. 1993;234:53-60.
18. Boberg M, Vessby B, Croon LB. Fatty acid composition of platelets and of plasma lipid esters in relation to platelet function in patients with ischaemic heart disease. Atherosclerosis. 1985;58:49-63.
19. Chen LY, Mehta JL. Further evidence of the presence of constitutive and inducible nitric oxide syntahase isoforms in human platelets. J Cardiovasc Pharmacol. 1996;27:154-158
20. Schwellenbach LJ, Olson KL, McConnell KJ, Stolcpart RS, Nash JD, Merenich JA; Clinical Pharmacy Cardiac Risk Service Study Group. The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides. J Am Coll Nutr. 2006;25:480-485
21. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr. 2002;76:1007-1015
22. Johansen O, Brekke M, Seljeflot I. N-3 fatty acids do not prevent restenosis after coronary angioplasty: results of the CART study. J Am Coll Cardiol. 1999;33:1619-1626
23. Luostarinen R, Wallin R, Wibell R, Saldeen T. Vitamin E supplementation counteracts the fish oil-induced increase in blood glucose in humans. Nutr Res. 1995;15:953-968
24. Allard JP, Kurian R, Aghdassi E, Muggli R, Royall D. Lipid peroxidation during n-3 fatty acid and vitamin E supplementation in humans. Lipids. 1997;32:535-541
25. Mori TA. Effect of fish and fish oil-derived omega-3 fatty acids on lipid oxidation. Redox Rep. 2004;9:193-197
26. Stevens LJ, Zentall SS, Abate ML. Omega-3 fatty acids in boys with behavior, learning and health problems. Physiol Behav. 1996;59:915-920
27. Willats P, Forsyth JS, DiModugno MK. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet. 1998;352:688-691
28. Birch EE, Hoffman DR, Uauy R, Birch DG, Prestidge C. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res. 1998;44:201-209
29. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids years age. Pediatrics. 2003;111:39-44.
30. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 2003;60:940-946
31. Sumida C, Graber R, Nunez E. Role of fatty acids in signal transduction: modulators and messengers. Prostaglandins Leukot Essent Fatty Acids. 1993;48:117-122
32. ObataT,NagakuraT,MasakiT. Eicosapentaenoic acid inhibits prostaglandin D2 by inhibition of cuclooxygenase-2 in cultured human mast cells. Clin Exp Allergy. 1999;29:1129-1133
33. Willumsen N, Vaagenes H, Lie O, Rustan AC, Berge RK. Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2,4-dienoyl- CoA reductase gene expression in rats. Lipids. 1996;31:579-592
34. Finnen MJ, Lovell CR. Purification and characterisation of phosphlipase A2 from human epidermis. Biochem Soc Trans. 1991;(19 suppl):91S.
35. GattazWF, KollischM, Thuren T, Virtanen JA, Kinnunen PK. Increased plasma phospholipase A2 activity in schizophrenic patients: reduction after neuroleptic therapy. Biol Psychiatry. 1987;22:421-426
36. Peet M, Brind J, Ramchand CN, Shah S, Vankar GK. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr Res. 2001;49:243-251
37. Busch B. Polyunsaturated fatty acid supplementation for ADHD? Fishy, fascinating, and far from clear. J Dev Behav Pediatr. 2007;28:139-144
38. Sinn N, Bryan J. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD. J Dev Behav Pediatr. 2007;28:82-91.
39. Sorgi PJ, Hallowell EM, Hutchins HL, Sears B. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Nutr J. 2007; 13:6-16.
40. Jensen MM, Skarsfeldt T, Hoy CE. Correlation between level of n-3 polyunsaturated fatty acids in brain phospholipids and learning ability in rats. A multiple generation study. Biochim Biophys Acta. 1996;1300:203-209
41. Lim SY, Suzuki H. Intakes of dietary docosahexaenoic acid ethyl ester and egg phosphatidylcholine improve mazelearning ability in young and old mice. J Nutr. 2000; 130:1629-1632
42. Moriguchi T, Greiner RS, Salem NJ. Behavioural deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem. 2000;75: 2563-2573
43. Li P, Kim SW, Li X, Datta S, Pond WG, Wu G. Dietary supplementation with cholesterol and docosahexaenoic acid increases the activity of the arginine-nitric oxide pathway in tissues of young pigs. Nitric Oxide. 2009;19:259-265
44. Saldeen AS, Yang B, Chen L, Engström K, Mehta JL, Saldeen T. Importance of long chain fatty acids and antioxidants in fish oils for their effect on vascular tissue and brain. J Investig Med. 1997;45:209A.